Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Idgie Health

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Idgie Health head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 99 · Grade C

Idgie Health

Visit Idgie Health Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 75 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make Idgie Health a bad call — it's best for readers who want to compare an explicit monthly payment with three- and six-month prepayment before starting an intake. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
66
Supply Reliability
95
80
Transparency
90
70
Access Breadth
93
88
Clinical Oversight
92
76
Track Record
88
72
CoreAge RxBrief Score 94 · 75Idgie Health

Price, coverage & the tracker

CoreAge RxIdgie Health
Brief Score94/100 (A)75/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

$149/mo paid monthly

Quarterly: $387 upfront; six months: $687 upfront.

Full price details

$149/month billed monthly; quarterly $387 upfront; six-month plan $687 upfront

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

$229/mo paid monthly

Quarterly: $557 upfront; six months: $1,029 upfront.

Full price details

$229/month billed monthly; quarterly $557 upfront; six-month plan $1,029 upfront

CoverageUS only; restrictions by state, confirmed at intakeA state-availability page is published
Brand-name accessNot confirmedNot confirmed
Oral / sublingualInjection onlyYes
On the trackerStableprice stableStableprice stable

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

Idgie Health: Monthly prices remain $149 for semaglutide and $229 for tirzepatide. Quarterly totals are $387 and $557 upfront; compare full charges rather than rounded monthly equivalents.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.